Regulatory Considerations for the Manufacture of Investigational Vaccines for Clinical Trials

First Page		Document Content
Pharmacology Clinical research Pharmaceutical industry Vaccination Food and Drug Administration Center for Biologics Evaluation and Research Vaccine Validation Biologic Biotechnology Medicine Pharmaceutical sciences		Regulatory Considerations for the Manufacture of Investigational Vaccines for Clinical Trials Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 494,88 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document